BioSpace News Archive

The global transfer membrane market size was USD 181 million in 2020 and is expected to register a CAGR of 1.7% during the forecast period.

MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1 ® in Peer-Reviewed Journal Drug Research.

Agilent Technologies Inc. (NYSE: A) today announced the release of the AssayMAP Bravo Protein Sample Prep Workbench 4.0 software.

Navidea Biopharmaceuticals, Inc. today announced its financial results for the three-month and nine-month periods ended September 30, 2022.

Neuronetics, Inc. announced today the latest advancements of the NeuroStar ® Advanced Therapy system, which enhance both the software and console and continue to build on the Company’s innovation momentum.

Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced financial results for the third quarter ended September 30, 2022 and provided a corporate update on key programs.

Agenus announced expanded data from the Company’s Phase 1 study of botensilimab (Fc-enhanced anti-CTLA-4) and balstilimab (anti-PD-1) in patients with treatment-resistant tumors, including MSS-CRC, ovarian, sarcoma and NSCLC.

Adial Pharmaceuticals, Inc today provided a business update and reported its financial results for the third quarter of 2022.

POINT Biopharma Global Inc. today announced financial results for the third quarter ended September 30, 2022, and provided an update on business highlights, including the announcement of a strategic collaboration and exclusive license agreements with Lantheus Holdings Inc.

BioT Medical, a company providing a validated cloud-native platform for building new care models based on Internet of Medical Things (IoMT) medical devices - in a day instead of years, announced a strategic agreement with NTT DATA, a digital business and IT services leader.